MarketCap
Facebook
X
TelegramAnnual report 2026
added 04-02-2026
IRIDEX Corporation Market Cap 2011-2026 | IRIX
As of April 08, 2026 IRIDEX Corporation has a market cap of $ 17.4 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap IRIDEX Corporation
| 2026 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.6 M | 16.1 M | 48.1 M | 36 M | 69.2 M | - | 36.7 M | 57.8 M | 85.4 M | 97.5 M | 96.3 M | - | 81.2 M | 36.4 M | 36 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 97.5 M | 16.1 M | 54.9 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 11.94 | -1.08 % | $ 1.61 B | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 9.07 | -3.3 % | $ 257 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 36.67 | -0.19 % | $ 5.46 K | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
FONAR Corporation
FONR
|
85.2 M | $ 18.58 | -0.11 % | $ 122 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.4 | -1.73 % | $ 127 M |  France |
 |
Globus Medical
GMED
|
12.5 B | $ 90.0 | 1.58 % | $ 12.2 B | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
13.9 B | $ 166.87 | -2.91 % | $ 12.5 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
1.5 B | $ 30.99 | -5.06 % | $ 1.43 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
766 M | $ 4.05 | -1.94 % | $ 857 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.61 | 3.37 % | $ 38 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 9.67 | -0.31 % | $ 346 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 1.83 | -3.68 % | $ 1.11 M | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
113 B | $ 61.86 | -1.12 % | $ 91.6 B | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 11.03 | 0.55 % | $ 1.66 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 9.33 | 0.21 % | $ 719 M | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 34.54 | 1.35 % | $ 1.07 B | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 85.11 | -0.61 % | $ 2.96 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 80.84 | -0.43 % | $ 47.3 B | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 54.42 | 0.52 % | $ 1.6 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 15.76 | -1.13 % | $ 370 M | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 5.63 | -4.41 % | $ 67.3 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Medtronic PLC
MDT
|
111 B | $ 86.42 | 0.15 % | $ 111 B | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | USA |
 |
Myomo
MYO
|
33.9 M | $ 0.68 | -2.9 % | $ 28.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Orthofix Medical
OFIX
|
491 M | $ 11.71 | -0.51 % | $ 464 M |  Curacao |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |